Rapid Test Detects Colistin Resistance Gene
Credit: JLU Gießen
Scientists from the German Center for Infection Research (DZIF) and the Justus Liebig University Giessen (JLU) have evaluated a rapid test that detects the dreaded colistin resistance gene within twenty minutes. It can therefore be used in hospitals and for livestock.
Colistin is used as the “last-resort antibiotic” for dreaded multidrug-resistant pathogens, especially in hospitals. However, gut bacteria that have become insensitive to colistin now exist—owing to the mobile resistance gene mcr-1. In early 2016, bacteria carrying this resistance gene were detected in Germany for the first time. Since then, there has been growing concern that it may develop into a “superbug” against which even emergency antibiotics are no longer effective. The risk of a further spread of this colisitin resistance is high because it takes place through so-called mobile genetic elements (plasmids) which are transferred between different types of bacteria relatively easily.
“Confirming the mobile mcr-1 resistance gene as rapidly as possible is important, so as to prevent its further spread,” emphasizes Linda Falgenhauer, DZIF scientist at the Justus Liebig University Giessen and one of the first authors of this study. Together with her colleagues from Giessen University and scientists from the research association RESET, she tested a rapid genotypic resistance test for colistin that is already commercially available. “This is the only way with which mobile resistance can be differentiated from common resistance, because phenotypically they are the same,” explains Can Imirzalioglu, who is also first author of the study and DZIF scientist at the Giessen University.
Getting results rapidly
For the evaluation of this rapid test, the scientists worked together with the company AmplexBiosystems GmbH which provided the testing kits free of charge. 104 bacterial isolates from animals, humans and the environment underwent testing with the molecular rapid test: the rapid test results were compared to those from complete genome sequencing or PCR, and demonstrated one hundred percent sensitivity and specificity.
The test could clearly differentiate between common colistin resistance and mobile resistance located on plasmids. “The test results become available in only twenty minutes,” explains Judith Schmiedel from the Giessen Team. “With the conventional procedure, it takes several hours to get results. Additionally, the system is very uncomplicated, so it should be developed further for future use in hospitals as well as for livestock farming and food production.” However, the rapid test is still limited because applying it directly to samples has not yet been evaluated. Up to now, the test has been only applied to bacterial cultures, but the scientists are certain that it is only a matter of time before it is developed further.
Imirzalioglu, C., Falgenhauer, L., Schmiedel, J., Waezsada, S., Gwozdzinski, K., Roschanski, N., . . . Chakraborty, T. (2017). Evaluation of a LAMP-based assay for the rapid detection of plasmid-encoded colistin resistance gene mcr-1 in Enterobacteriaceae isolates. Antimicrobial Agents and Chemotherapy. doi:10.1128/aac.02326-16
Biological Fingerprint of Tuberculosis Meningitis Discovered in ChildrenNews
Children with tuberculosis meningitis have a biological fingerprint that can be used to assess the severity of the condition, help decide the best course of treatment, and provide clues for novel treatments.READ MORE
Exosomes Offer Significant Potential in Detecting and Treating DiseaseNews
Exosomes - tiny biological nanoparticles which transfer information between cells - offer significant potential in detecting and treating disease, the most comprehensive overview so far of research in the field has concluded.READ MORE
FDA Approves First Companion Diagnostic Test to Simultaneously Screen for Multiple Non-Small Cell Lung Cancer TherapiesNews
Oncomine Dx Target Test returns results in days, helping physicians rapidly develop treatment plans for the most common form of lung cancer.
Comments | 0 ADD COMMENT
3rd World Congress on Human Genetics & Genetic Disorders
Oct 20 - Oct 21, 2017